These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37643022)

  • 1. Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease.
    Kalashyan M; Raghunathan K; Oller H; Bayer MT; Jimenez L; Roland JT; Kolobova E; Hagen SJ; Goldsmith JD; Shub MD; Goldenring JR; Kaji I; Thiagarajah JR
    J Clin Invest; 2023 Oct; 133(20):. PubMed ID: 37643022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy Development for Microvillus Inclusion Disease using Patient-derived Enteroids.
    Kalashyan M; Raghunathan K; Oller H; Theres MB; Jimenez L; Roland JT; Kolobova E; Hagen SJ; Goldsmith JD; Shub MD; Goldenring JR; Kaji I; Thiagarajah JR
    bioRxiv; 2023 Jan; ():. PubMed ID: 36747680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
    Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
    Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of intestinal ion transport defects in microvillus inclusion disease.
    Kravtsov DV; Ahsan MK; Kumari V; van Ijzendoorn SC; Reyes-Mugica M; Kumar A; Gujral T; Dudeja PK; Ameen NA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G142-55. PubMed ID: 27229121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity.
    Thoeni CE; Vogel GF; Tancevski I; Geley S; Lechner S; Pfaller K; Hess MW; Müller T; Janecke AR; Avitzur Y; Muise A; Cutz E; Huber LA
    Traffic; 2014 Jan; 15(1):22-42. PubMed ID: 24138727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of MYO5B Leads to Reductions in Na
    Engevik AC; Kaji I; Engevik MA; Meyer AR; Weis VG; Goldstein A; Hess MW; Müller T; Koepsell H; Dudeja PK; Tyska M; Huber LA; Shub MD; Ameen N; Goldenring JR
    Gastroenterology; 2018 Dec; 155(6):1883-1897.e10. PubMed ID: 30144427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.
    Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of mutations in the myosin Vb gene associated with microvillus inclusion disease.
    Szperl AM; Golachowska MR; Bruinenberg M; Prekeris R; Thunnissen AM; Karrenbeld A; Dijkstra G; Hoekstra D; Mercer D; Ksiazyk J; Wijmenga C; Wapenaar MC; Rings EH; van IJzendoorn SC
    J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):307-13. PubMed ID: 21206382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview and online registry of microvillus inclusion disease patients and their MYO5B mutations.
    van der Velde KJ; Dhekne HS; Swertz MA; Sirigu S; Ropars V; Vinke PC; Rengaw T; van den Akker PC; Rings EH; Houdusse A; van Ijzendoorn SC
    Hum Mutat; 2013 Dec; 34(12):1597-605. PubMed ID: 24014347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.
    Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.
    Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD
    J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking.
    Schneeberger K; Vogel GF; Teunissen H; van Ommen DD; Begthel H; El Bouazzaoui L; van Vugt AH; Beekman JM; Klumperman J; Müller T; Janecke A; Gerner P; Huber LA; Hess MW; Clevers H; van Es JH; Nieuwenhuis EE; Middendorp S
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12408-13. PubMed ID: 26392529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease.
    Schlegel C; Weis VG; Knowles BC; Lapierre LA; Martin MG; Dickman P; Goldenring JR; Shub MD
    Dig Dis Sci; 2018 Feb; 63(2):356-365. PubMed ID: 29218485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The zebrafish goosepimples/myosin Vb mutant exhibits cellular attributes of human microvillus inclusion disease.
    Sidhaye J; Pinto CS; Dharap S; Jacob T; Bhargava S; Sonawane M
    Mech Dev; 2016 Nov; 142():62-74. PubMed ID: 27497746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered MYO5B Function Underlies Microvillus Inclusion Disease: Opportunities for Intervention at a Cellular Level.
    Bowman DM; Kaji I; Goldenring JR
    Cell Mol Gastroenterol Hepatol; 2022; 14(3):553-565. PubMed ID: 35660026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Rab11-Rab8-vesicles cluster in enterocytes of patients with microvillus inclusion disease.
    Vogel GF; Janecke AR; Krainer IM; Gutleben K; Witting B; Mitton SG; Mansour S; Ballauff A; Roland JT; Engevik AC; Cutz E; Müller T; Goldenring JR; Huber LA; Hess MW
    Traffic; 2017 Jul; 18(7):453-464. PubMed ID: 28407399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
    Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
    Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model.
    Ruemmele FM; Müller T; Schiefermeier N; Ebner HL; Lechner S; Pfaller K; Thöni CE; Goulet O; Lacaille F; Schmitz J; Colomb V; Sauvat F; Revillon Y; Canioni D; Brousse N; de Saint-Basile G; Lefebvre J; Heinz-Erian P; Enninger A; Utermann G; Hess MW; Janecke AR; Huber LA
    Hum Mutat; 2010 May; 31(5):544-51. PubMed ID: 20186687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The localisation of the apical Par/Cdc42 polarity module is specifically affected in microvillus inclusion disease.
    Michaux G; Massey-Harroche D; Nicolle O; Rabant M; Brousse N; Goulet O; Le Bivic A; Ruemmele FM
    Biol Cell; 2016 Jan; 108(1):19-28. PubMed ID: 26526116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic Acid Increases Maturation of Brush Borders and SGLT1 Activity in MYO5B-deficient Mice, a Model of Microvillus Inclusion Disease.
    Kaji I; Roland JT; Watanabe M; Engevik AC; Goldstein AE; Hodges CA; Goldenring JR
    Gastroenterology; 2020 Oct; 159(4):1390-1405.e20. PubMed ID: 32534933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.